Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 30Terminated 7Unknown 3Active not recruiting 3Withdrawn 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 16Lymphoid 11Other hematologic neoplasm 6Dermatologic 4Sarcoma 2Myeloid 2CNS 1

Conditions

Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Melanoma 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 9Radiotherapy 8Temozolomide 6Magnetic Resonance Spectroscopy 6Filgrastim 6Doxorubicin 6pazopanib 5Gemcitabine 5pembrolizumab 4Vincristine 4Radiation 4Etoposide 4Docetaxel 4Carboplatin 4Biopsy 4Trabectedin 3Taxes 3Specimen Handling 3Paclitaxel 3Nivolumab 3Irinotecan 3Drug Therapy 3olaparib 2niraparib 2liposomal doxorubicin 2fludarabine phosphate 2fludarabine 2brigimadlin 2Trastuzumab 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Melphalan × Sarcoma × Clear all
NCT01969942 2017-05-09

ASCT

University of Louisville

Phase 1 Withdrawn
Sarcoma

Sarcoma, Ewing

NCT02507076 2015-07-23

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Albert Einstein College of Medicine

Phase NA Withdrawn
DermatologicSarcoma

Carcinoma, Basal Cell, Melanoma, Sarcoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡